US 7884111
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
granted A61KA61K31/4353A61K31/505
Quick answer
US patent 7884111 (2,4-pyrimidinediamine compounds and uses as anti-proliferative agents) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4353, A61K31/505, A61K31/506, A61P